山形大学医学部内科学第三講座・第三内科
血液内科
脳神経内科
糖尿病内科・代謝内分泌内科
所在地 | 〒990-9585 |
---|
医学生・研修医の方へ
当講座の研究業績をご紹介いたします。
(1) 原著
1)Hiroshima Y, Tajima K, Shiono Y, Suzuki Y, Kouno K, Yamamoto M, Kato Y, Kato T: Rituximab pharmacokinetics in ascites and serum in the treatment of follicular Iymphoma with massive ascites. Ann Hematol. 2012; 91(9)1499-1500
2)Shi Z, Hayashi YK, Mitsuhashi S, Goto K, Kaneda D, Choi YC, Toyoda C, Hieda S, Kamiyama T, Sato H, Wada M, Noguchi S, Nonaka I, Nishino I: Characterization of the Asian myopathy patients with VCP mutations.European Journal of Neurology. 2012; 19: 501-509
3)Daimon M, Konta T, Oizumi T, Karasawa S, Kaino W, Takase K, Jimbu Y, Wada K, Kameda W, Susa S, Saito T, Kubota I,Kayama T,Kato T: Higher plasma renin activity is a risk factor for total mortality in older Japanese individuals: the Takahata study. Metabolism Clinical and Experimental. 2012; 61: 504-511
4)Koyama S,Kawanami T,Arawaka S,Wada M,Kato T: A Japanese adult case of megalencephalic leukoencephalopathy with subcortical cysts with a good long-term prognosis. Internal Medicine.
2012; 51: 503-506
5)Hiraka T, Koyama S, Kurokawa K, Tanji H, Iseki C, Wada M, Kawanami T, Oda A, Hosoya T, Kato T: Reversible distension of the subarachnoid space around the optic nerves in a case of idiopathic hypertrophic pachymeningitis. Magnetic Resonance in Medical Sciences. 2012; 11(2)141-144
6)Koike H, Tanaka F, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Fujitake J, Kawanami T, Kato T, Yamamoto M, Sobue G: Natural history oftranshyretinVal30Metfamilialamyloidpolyneuropathy:analysisoflate-onsetcasesfromnon-endemic areas. J Neurol Neurosurg Psychiatry. 2012; 83: 152-158
7)Koyama S, Kawanami T, Kurokawa K, Tanji H, Iseki C, Arawaka S, Wada M, Kato T: Carpal tunnel syndrome as an initial manifestation in a case of transthyretin-related familial amyloid polyneuropathy with a novel A120T mutation. Clinical Neurology and Neurosurgery. 2012; 114: 707-709
8)Daimon M, Kato T, Kaino W, Takase K, Karasawa S, Wada K, Kameda W, Susa S, Oizumi T, Tomita Y, Kato T: Thyroid dysfunction in patients treated with tyrosine kinase inhibitors,sunitinib, sorafenib and axitinib, for metastatic renal cell carcinoma. Jpn J Clin Oncol. 2012; 42(8): 742-747
9)Kohno K, Kimura Y, Kiyasu J, Miyoshi H, Yoshida M, Ichikawa R, Niino D, Ohshima K: Malignant lymphoma of the spleen in Japan:A clinicopathological analysis of 115 cases. Pathology International.
2012; 62: 577-582
10)Kato Y, Tajima K, Suzuki I, Kohno K, Hiroshima Y, Kato T: The pharmacokinetic analysis of cyclosporine is essential for the management of refractory pure red cell aplasia. Ann Hematol.
2012; 91(12)1991-1992
11)Iseki C, Takahashi Y, Wada M, Arawaka S, Kawanami T, Kato T: Changes in the subarachnoid space precede ventriculomegaly in idiopathic normal pressure hydrocephalus(iNPH). Internal Medicine.2012; 51: 1751-1753
12)Tanji H, Nakajima K, Wada M, Kato T: Alterations of the cerebral white matter in a middle-aged patient with Turner syndrome: An MRI study. Case Reports in Neurology. 2012; 4: 144-148
13)Takahashi Y, Koyama S, Tanaka H, Arawaka S, Wada M, Kawanami T, Haga H, Watanabe H, Toyota K, Numakura C, Hayasaka K, Kato T: An elderly Japanese patient with adult-onset type II citrullinemia with a novel D493G mutation in the SLC25A13 gene. Internal Medicine. 2012; 51: 2131-2134
14)Mizuta K, Kuroda M, Kurimura M, Yahata Y, Sekizuka T, Aoki Y, Ikeda T, Abiko C, Nada M, Kimura H, Mizutani T, Kato T, Kawanami T, Ahiko T: Epidemic myalgia in adults associated with human parechovirus type 3 infection, Yamagata, Japan, 2008. Emerging Infectious Diseases. 2012; 18(11): 1787-1793
15)Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, miyajima M, Nakajima M, Hashimoto M, Kuriyama N, Tokuda T, Ishii K, Kaijima M, Hirata Y, Saito M, Arai H: Guidelines for management of idiopathic normal pressure hydrocephalus: second edition.Neurologia Medico-Chirurgica. 2012; 52(11): 775-809
16)Kato T, Tamiya G, Koyama S, Nakamura T, Makino S, Arawaka S, Kawanami T, Tooyama I: UBR5 gene mutation is associated with familial adult myoclonic epilepsy in a Japanese family. ISRN Neurology. 2012; Article ID 508308: 4pages
17)Takahasi M, Ishikawa K, Sato N, Obayashi M, Niimi Y, Ishiguro T, Yamada M, Toyoshima Y, Takahashi H, Kato T, Takao M, Murayama S, Mori O, Eishi Y, Mizusawa H: Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6(SCA6) cerebellum. Neuropathology. 2012; 32: 595-603
18)Koyama S, Kawanami T, Tanji H, Arawaka S, Wada M, Saito N, Kato T: A case of cerebrotendinous xanthomatosis presenting with epilepsy as an initial symptom with a novel V413D mutation in the CYP27A1 gene. Clinical Neurology and Neurosurgery. 2012; 114: 1021-1023
19)Li H, Kilpelainen TO, Liu C, Zhu J, Liu Y, Hu C, Yang Z, Zhang W, Bao W, Cha S, Wu Y, Yang T, Sekine A, Choi BY, Yajnik, Zhou D, Takeuchi F, Yamamoto K, Chan JC, Mani KR, Been LE, Imamura M, Nakashima E, Lee N, Fujisawa T, Karasawa S, Wen W, Joglekar CV, Lu W, Chang Y, Xiang Y, Gao Y, Liu S, Song Y, Kwak SH, Shin HD, Park KS, Fall CHD, Kim JY, Sham PC, Lam KS L, Zheng W, Shu X, Deng H, Krishnaveni GV, Sanghera DK, Chuang L, Liu L, Hu R, Kim Y, Daimom M, Hotta K, Jia W, Kooner JS, Chambers J, Chandak JR, Ma RC, Maeda S, Dorajoo R, Yokota M, Takayanagi R, Kato N, Lin X, Loos: Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96, 551 East and South Asians. Diabetologia. 2012; 55: 981-995
20)The Emerging Risk Factors collaboration(FUNAGATA: Daimon M, Oizumi T, Kayama T, Kato T): Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.International Journal of Epidemiology. 2012; 41: 1419-1433
21)Yamaguchi Y, Nagasawa H, Yamakawa T, Kato T: Bow hunter's syndrome after contralateral vertebral artery dissection. Journal of Stroke and Cerebrovascular Diseases.2012; 21(8): 916.e7-9
22)Narumi T, Shishido T, Kiribayashi N, Kadowaki S, Nishiyama S, Takahashi H, Arimoto T, Miyashita T, Miya moto T, Watanabe T, Shibata Y, Konta T, Ueno Y, Kato T, Kayama T, Kubota I:
Impact of insulin resistance on silent and ongoing myocardial damage in normal subjects:
the Takahata study. Exp Diabetes Res. 2012; 2012: 815098. doi: 10. 1155/2012/815098
23)Hiroshima Y, Tajima K, Shiono Y, Suzuki I, Kohno K, Kato Y, Kawamura S, Kato T: Soft J-tipped guide wire-induced cardiac perforation in a patient with right ventricular lipomatosis and wall thinning. Internal Medicine: 2012; 51: 2609-2612
24)和田学: Small-vessel diseaseと認知機能. 循環器内科. 2012; 71(2)133-139
25)大門真,大泉俊英,加藤丈夫:疫学研究・大規模臨床試験より得られたEBM.日本臨床.2012; 70(3): 256-259
26)亀田亘,高瀬薫,大門真,加藤丈夫: ソマトスタチン受容体シンチグラフィーの使用経験例.内分泌・糖尿病・代謝内科.2012; 34(3): 285-286
27)佐藤秀則,江見充:ゲノムコピー数多型解析(CNV)と疾患研究.ホルモンと臨床.2012; 59: 17-22
28)山口佳剛,和田学,栗田啓司,高橋幸利,加藤丈夫:SLEを背景とし、病態に抗グルタミン酸受容体抗体の関与が示唆された自己免疫疾患関連性辺緑系脳炎の1例.臨床神経学.2012; 52(8): 545-550
29)伊関千書,丹治治子,和田学,川並透,加藤丈夫:長時間経過を観察し得た腓腹筋肥大を伴うS1神経根症の1症例.神経内科.2012; 77(4): 417-419
30)永沢光,山口佳剛,小野洋也,田中英智,山川達志:ダビガドランの投与によりAPTTが過剰延長した症例と出血性合併症を呈した症例の特徴.脳卒中.2012; 34(6)別綴: 435-437
(2) 著書
1)川並透:一酸化炭素中毒.内科学(総編集).東京;西村書店 2012: 518-521
2)栗山長門,宮田元,加藤丈夫:特発性正常圧水頭症の疫学,病理.老年精神医学雑誌.2012; 23: 800-806
(3) その他
1)川並透:神経・精神・運動器疾患.Year note(22版).東京;メデック メディア2012: J14-J28
2)加藤丈夫,川並透,荒若繁樹: パーキンソン病とその類似疾患.Pharma Medica. 2012; 30(11): 71-80
2011年度はこちらをクリック
2013年度はこちらをクリック